We are live on ! Find out more
ADMS

Adamas Pharmaceuticals
ADMS

Delisted

ADMS was delisted on the 23rd of November, 2021.

Back to rankings

93 hedge funds and large institutions have $316M invested in Adamas Pharmaceuticals in 2015 Q4 according to their latest regulatory filings, with 25 funds opening new positions, 28 increasing their positions, 25 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

699% more call options, than puts

Call options by funds: $831K | Put options by funds: $104K

81% more capital invested

Capital invested by funds: $175M → $316M (+$141M)

67% more first-time investments, than exits

New positions opened: 25 | Existing positions closed: 15

50% more funds holding in top 10

Funds holding in top 10: 2 → 3 (+1)

12% more funds holding

Funds holding: 83 → 93 (+10)

12% more repeat investments, than reductions

Existing positions increased: 28 | Existing positions reduced: 25

Holders
93
Holders Change
+10
Holders Change %
+12.05%
% of All Funds
2.44%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.08%
New
25
Increased
28
Reduced
25
Closed
15
Calls
$831K
Puts
$104K
Net Calls
+$727K
Net Calls Change
+$727K

Top Buyers

Rank Fund Capital Flow
1
GPP
Great Point Partners
Connecticut
+$5.51M
2
Millennium Management
Millennium Management
New York
+$5.38M
3
BFA
BlackRock Fund Advisors
California
+$3.89M
4
Citadel Advisors
Citadel Advisors
Florida
+$3.86M
5
SFM
Sphera Funds Management
Israel
+$2.53M

Top Sellers

Rank Fund Capital Flow
1
CPH
C Partners Holding
Switzerland
-$8M
2
BS
Bow Street
New York
-$2.54M
3
Renaissance Technologies
Renaissance Technologies
New York
-$2.38M
4
WSA
Wall Street Associates
California
-$1.68M
5
TC
TFS Capital
Pennsylvania
-$1.66M
Name Holding Trade Value Shares
Change 		Change in
Stake
Geode Capital Management
26
Geode Capital Management
Massachusetts
$2.12M +$393K +23,349 +45%
Dimensional Fund Advisors
27
Dimensional Fund Advisors
Texas
$1.97M +$998K +59,285 +585%
Ameriprise
28
Ameriprise
Minnesota
$1.84M +$1.09M +64,978 New
Bank of New York Mellon
29
Bank of New York Mellon
New York
$1.73M +$88.3K +5,248 +9%
TC
30
TFS Capital
Pennsylvania
$1.72M -$1.66M -98,582 -62%
IHM
31
Iguana Healthcare Management
New York
$1.7M +$1.01M +60,000 New
JP Morgan Chase
32
JP Morgan Chase
New York
$1.56M -$114K -6,747 -11%
PAM
33
Private Asset Management
California
$1.16M – – –
BIM
34
BlackRock Investment Management
Delaware
$1.15M +$3.43K +204 +0.5%
TAM
35
Tocqueville Asset Management
New York
$1.13M +$253K +15,000 +60%
SO
36
STRS Ohio
Ohio
$1.13M +$214K +12,700 +47%
BA
37
BlackRock Advisors
Delaware
$1.01M -$154K -9,148 -20%
ZIM
38
Zacks Investment Management
Illinois
$987K -$176K -10,481 -23%
TCIM
39
TIAA CREF Investment Management
New York
$983K – – –
D.E. Shaw & Co
40
D.E. Shaw & Co
New York
$976K +$278K +16,538 +92%
JAM
41
JW Asset Management
Florida
$854K – – –
Acadian Asset Management
42
Acadian Asset Management
Massachusetts
$850K -$1.26M -75,005 -71%
BOS
43
Bingham Osborn & Scarborough
California
$850K – – –
AA
44
ALPS Advisors
Colorado
$687K -$61.1K -3,628 -13%
GC
45
Globeflex Capital
California
$612K +$364K +21,598 New
Marshall Wace
46
Marshall Wace
United Kingdom
$605K -$800K -47,500 -69%
Two Sigma Investments
47
Two Sigma Investments
New York
$563K +$335K +19,876 New
California State Teachers Retirement System (CalSTRS)
48
California State Teachers Retirement System (CalSTRS)
California
$545K +$6.21K +369 +2%
HCM
49
Highbridge Capital Management
New York
$464K +$276K +16,375 New
ProShare Advisors
50
ProShare Advisors
Maryland
$462K +$275K +16,327 New
1
2
3 4 5

ADMS Hedge Fund Activity: Q4 2015 in Review

93 of the 3,812 institutional investors tracked by Wall St. Rank reported a position in Adamas Pharmaceuticals (ADMS) for Q4 2015, worth a combined $316M — up 81% from $175M a quarter earlier.

Buyers outnumbered sellers: 25 funds opened new ADMS positions and 15 closed out — a net gain of 10 holders — while 28 added to existing stakes and 25 trimmed.

The largest buyer was Great Point Partners, adding an estimated $5.51M. The largest seller was C Partners Holding, cutting an estimated $8M.

  • 93 institutional investors held Adamas Pharmaceuticals (ADMS) as of Q4 2015, up from 83 in Q3 2015.
  • Funds reported $316M of Adamas Pharmaceuticals stock for Q4 2015, up 81% quarter-over-quarter.
  • 25 funds opened new Adamas Pharmaceuticals positions in Q4 2015 and 15 closed out, a net change of +10 holders.
  • The largest Adamas Pharmaceuticals buyer in Q4 2015 was Great Point Partners, an estimated $5.51M added.
  • The largest Adamas Pharmaceuticals seller in Q4 2015 was C Partners Holding, an estimated $8M sold.

Based on aggregated 13F filings for Q4 2015.